GORNATI ROSALBA

Full professor of comparative anatomy and cell biology (SSD BIO/06) at the Department of Biotechnology and Life Sciences (DBSV), University of Insubria. She is president of the Joint Faculty–Student Committee. In 1990, she graduated in pharmacy at the University of Milan. In 1993 and 1995, she was Visiting Researcher at the University of Notre Dame (Indiana, USA) where she studied the activity of enzymes involved in the glyco-sphingolipid pathway. Since 2007 she is a member of the PhD Board in Life Sciences and Biotechnology. She has been Supervisor and Tutor of numerous PhD and master' students. Scientific Activities: She studied membrane lipid expression and enzyme activities, involved in their biosynthesis, as diagnostic method in sphingolipidosis and as potential biomarkers for neoplasia (LS2_8). She also used Xenopus laevis embryos for FETAX (Frog Embryo Teratogenesis Assay in Xenopus) bioassay to evaluate the teratogenic risk of xenobiotics (LS3_6 and LS3_7). She is also interested in toxicity and gene expression modifications induced by metal nanoparticles both in cell cultures and in animals (LS2_8). Currently, one of the research project is focused on the study of nanoparticle systems for biotechnological and medical uses (LS9_2 and LS3_12). This research was awarded by “Telecom Italia working capital” and by European Commission H2020 “HOTZYMES” Grant Agreement Number 829162. The second research project is focused on the study of mesenchymal stem cells and their derivatives, in combination or not with biocompatible scaffolds for applications in regenerative medicine (LS3_12) and granted by Integra LifeSciences, a global medical device manufacturing company in Princeton, New Jersey. PAST COLLABORATION S ECVAM e IHCP, European Commission Joint Research Center-Ispra (IT); Division of Hematology and Oncology Texas Tech University (USA); Center of Bionano Interaction, University College Dublin (Eire); Laboratoire Catalyse et Spectrochimie Université de Caen Normandie (F); Dipartimento di Biologia, Università di Pisa; Dipartimento di Scienze della Vita, Università di Siena; Dipartimento di Scienze della Vita, Università degli studi di Trieste; Istituti Clinici Scientifici Maugeri SpA-SB, IRCCS Pavia; Veneto Nanotech, ECSIN-Rovigo; Fondazione Filarete, Milano; Dipartimento di Biologia, Università degli Studi di Napoli; Dipartimento di Scienze, Università degli Studi Roma Tre; Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento; Dipartimento di Scienze Fisiche, della Terra e dell’ambiente, Università di Siena. Dipartimento di Medicina e Scienze Dell'invecchiamento, Università degli Studi "G. d'Annunzio "Chieti – Pescara; il Dipartimento di Chimica, Materiali e Ingegneria Chimica "Giulio Natta”, Politecnico di Milano; Dipartimento di Ingegneria Elettrica Elettronica e Informatica, Università degli Studi di Catania, Dipartimento di Scienze Biologiche e Ambientali, Università degli Studi di Messina; Istituto per l'Ambiente Marino Costiero del Consiglio Nazionale delle Ricerche (IAMC-CNR) di Messina; Dipartimento di Medicina e Chirurgia, Università degli Studi dell’Insubria; Department of Veterinary Medicine, University of Cambridge (UK). CURRENT COLLABORATIONS AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) Madrid-Spain; FORSCHUNGSZENTRUM JULICH GMBH (FZJ), Julich-Germany; UNIVERSIDAD DE ZARAGOZA (UZ), Zaragoza; TECHNISCHE UNIVERSITAET GRAZ (TUG), Graz-Austria; NANOSCALE BIOMAGNETICS SOCIEDAD LIMITADA (nB), Zaragoza-Spain; ACIB GmbH (ACIB), GRAZ-Austria; SWISS STEM CELL FOUNDATION, Gentilino (CH); Università degli Studi di Milano Bicocca-Dipartimento di Scienze dell'Ambiente e del Territorio e di Scienze della Terra; Università degli Studi di Milano-Dipartimento di Bioscienze, Università degli Studi di Messina-Dipartimento di Scienze Biologiche e Ambientali. Funded projects 2019-2022: particip